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T-bet is a critical transcription factor for T helper 1
(Th1) cell differentiation. To study the regulation
and functions of T-bet, we developed a T-bet-
ZsGreen reporter mouse strain. We determined that
interleukin-12 (IL-12) and interferon-g (IFN-g) were
redundant in inducing T-bet in mice infected with
Toxoplasma gondii and that T-bet did not contribute
to its own expression when induced by IL-12 and
IFN-g. By contrast, T-bet and the transcription factor
Stat4 were critical for IFN-g production whereas
IFN-g signaling was dispensable for inducing IFN-g.
Loss of T-bet resulted in activation of an endogenous
program driving Th2 cell differentiation in cells ex-
pressing T-bet-ZsGreen. Genome-wide analyses
indicated that T-bet directly induced many Th1 cell-
related genes but indirectly suppressed Th2 cell-
related genes. Our study revealed redundancy and
synergy among several Th1 cell-inducing pathways
in regulating the expression of T-bet and IFN-g, and
a critical role of T-bet in suppressing an endogenous
Th2 cell-associated program.
INTRODUCTION
CD4+ T helper (Th) cells play critical roles in orchestrating
adaptive immune responses to pathogens, mainly through
cytokine production (Murphy and Reiner, 2002; Zhu et al.,
2010). They are also involved in pathological responses to
self-antigens and to nonharmful allergens, resulting in autoim-
mune and allergic diseases, respectively. Activated CD4+
T cells are classified on the basis of their capacity to produce
unique cytokines, their distinct homing properties, and their
particular functions during various immune responses. They
develop from naive CD4+ T cells when antigen-specific T cell
receptors (TCRs) as well as cytokine receptors on these cells
are activated.660 Immunity 37, 660–673, October 19, 2012 ª2012 Elsevier Inc.In vitro, interleukin-12 (IL-12)- and interferon (IFN)-g-mediated
signaling, through the activation of the transcription factors
Stat4 and Stat1, respectively, together with TCR activation, are
important for T helper type 1 (Th1) cell differentiation. IL-2 and
IL-4 are critical for T helper type 2 (Th2) cell differentiation (Ansel
et al., 2006; Oestreich and Weinmann, 2012; Zhu et al., 2010).
T-bet is a critical transcription factor of Th1 cells. It plays an
important role in regulating IFN-g production (Szabo et al.,
2000; Szabo et al., 2002). Naive CD4+ T cells do not express
T-bet. IFN-g has been shown to induce T-bet expression, which
results in a potential positive feedback loop during Th1 cell
differentiation (Afkarian et al., 2002; Lighvani et al., 2001). IL-12
also induces T-bet in an IFN-g-Stat1-independent manner in
CD8+ T cells (Yang et al., 2007). The relative importance of
IL-12 and IFN-g in T-bet induction as well as IFN-g expression
especially during in vivo Th1 cell responses has not been estab-
lished. Furthermore, retroviral T-bet has been reported to induce
endogenous T-bet expression (Mullen et al., 2001); however,
whether endogenous T-bet directly regulates its own expression
or does so indirectly through its upregulation of IFN-g and/or
IL-12Rb2 is still unclear.
Similarly, the mechanism of Th2 cell differentiation in vivo has
been an enigma since the earliest demonstration of the Th2 cell
differentiation process. IL-4 plays an essential role for Th2 cell
differentiation in vitro. Assuming a comparable role for IL-4
in vivo, the source of such IL-4 remains controversial, particularly
given that professional antigen-presenting cells (APCs), such as
dendritic cells, do not produce IL-4. Recently, it has been
proposed that basophils serve as Th2 cell-promoting APCs
and that they produce IL-4 and/or thymic stromal lymphpoietin
(TSLP) for such a purpose (Perrigoue et al., 2009; Sokol et al.,
2008; Sokol et al., 2009; Yoshimoto et al., 2009). However,
the role of basophils in antigen presentation remains controver-
sial (Kim et al., 2010). Furthermore, Th2 cell differentiation in
several, but not all, parasite infection models occurs in IL-4-,
IL-4Ra- or Stat6-deficient mice, indicating that IL-4-mediated
signaling is not essential for initiating Th2 cell differentiation
in vivo (Finkelman et al., 2000; Jankovic et al., 2000; Min et al.,
2004; Voehringer et al., 2004). It has been proposed that Th2
cell differentiation may occur through a default pathway;
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T-bet Prevents an Endogenous Th2 Cell Programhowever, CD4+ T cells in IL-12-deficient mice fail to default to
Th2 cells in response to intracellular pathogens (Jankovic
et al., 2002).
GATA3 is the critical transcription factor for Th2 cell differenti-
ation both in vitro and in vivo (Pai et al., 2004; Zhang et al., 1997;
Zheng and Flavell, 1997; Zhu et al., 2004). GATA3 is also indis-
pensable for CD4+ T cell development in the thymus at multiple
stages and thus, unlike T-bet, which is not expressed in naive
CD4+ T cells, GATA3 is detected in naive CD4+ T cells (Ho
et al., 2009). IL-4-mediated Stat6 activation is the main inducing
signal for GATA3 upregulation in vitro. T cell receptor activation,
particularly with low-dose antigen, also upregulates GATA3
expression (Yamane et al., 2005). On the other hand, GATA3 is
downregulated during Th1 cell differentiation. Th2 cells may
develop with low amounts of GATA3 expression but even in
such cases, GATA3 is essential (Zhu et al., 2003); thus, constitu-
tive expression of GATA3 at certain amounts in naive CD4+
T cells is consistent with an endogenous Th2 cell program. The
failure of CD4+ T cells to default to Th2 cells in an IL-12-deficient
setting suggests that either this endogenous Th2 cell-inducing
program does not exist or that there are other Th1 cell-inducing
signals, such as IFN-g, that are responsible for suppressing this
program.
To study the CD4+ T cell differentiation process and cross-
regulation both in vitro and in vivo, we developed a T-bet reporter
mouse strain. Using this research tool, we observed that IL-12
and IFN-g were redundant in inducing T-bet during in vitro
culture and in vivo immune responses to T. gondii. IFN-g
signaling was dispensable for generating IFN-g-producing
T cells under the conditions tested. Furthermore, T-bet collabo-
rated with Stat4 in inducing IFN-g production but was not
required for its own expression in the presence of IL-12 and
IFN-g. When T-bet was absent, T. gondii infection elicited
expression of the T-bet reporter while inducing a Th2 cell
differentiation program, including IL-4 production and GATA3
upregulation, in the same cells. Our result suggests that an
endogenous program for in vivo Th2 cell differentiation exists
and that it is normally repressed by T-bet during Th1 cell differ-
entiation. In the absence of T-bet, this program can be activated
in the absence of Th2 cell-stimulating cytokines.
RESULTS
T-bet-ZsGreen Reporter Faithfully Reflects
the Expression of Endogenous T-bet
To study the regulation of T-bet expression and the functions of
T-bet-expressing cells both in vitro and in vivo, we generated
a bacterial artificial chromosome (BAC) transgenic T-bet reporter
mouse strain. The coding region of ZsGreen (ZsG), an improved
version of green fluorescent protein (GFP), was inserted into the
T-bet translational start site in the BAC clone RP23-237M14.
From such design, ZsG but not T-bet protein will be expressed
from the transgenic BAC; T-bet will continue to be expressed
from the endogenous Tbx21 gene. The reporter strain was
designated the T-bet green reporter (TBGR).
ZsG expression was detected in subsets of splenocytes and
lymph node cells from unimmunized TBGR mice (Figure 1A
and Figure S1 available online). Approximately 40% of memory
phenotype splenic CD4+ T cells (CD4+Foxp3negCD44hi cells)were ZsG positive (ZsG+). All the CD4+CD44low cells were
ZsG negative (ZsGneg). A proportion of regulatory T cells
(CD4+Foxp3+) cells (15%) were found to express intermediate
amounts of ZsG. In the CD8+ T cell compartment, all the cells
that expressed high amounts of ZsG were CD44hi. Some cells
that expressed intermediate amounts of ZsG and CD44 may
represent cells at a transition stage from naive to memory-like
CD8+ T cells.
As expected, TbetmRNA (Tbx21) was only detected in sorted
CD4+CD44hiZsG+ cells (Figure 1B). Only the ZsG+ cells ex-
pressed Ifng mRNA. Rorc mRNA was enriched in ZsGneg cells,
suggesting the ZsGneg fraction contains Th17 cells. We have
previously reported that Th17 cells express lower GATA3 than
Th1 cells do (Wei et al., 2011). The fact that Gata3 mRNA was
not differentially expressed in the ZsG+ and ZsGneg cells sug-
gests that the ZsGneg fraction contains some Th2 cells (Fig-
ure 1B). A comparison of splenic CD4+Foxp3neg T cells showed
an excellent correlation between expression of ZsG and T-bet as
assessed by flow cytometric analysis (Figure 1C). These results
indicate that the ZsG reporter in TBGR mice faithfully reflects
T-bet-expressing cells developed in vivo and that ZsG is much
more powerful than anti-T-bet in detecting and separating
T-bet-expressing cells from T-bet-nonexpressing cells.
To evaluate T-bet-ZsGreen expression under conditions of
Th cell polarization, we stimulated naive CD4+ T cells (CD4+
CD62LhiCD44lowCD25negZsGneg) with soluble anti-CD3 plus
anti-CD28 under Th1, Th2, or Th17 (IL-17-producing T helper
cells) cell-polarizing conditions for 3 days in vitro. Almost all cells
in the Th1 cell-polarizing culture (>95%) expressed high
amounts of ZsG, whereas, under Th2 or Th17 cell-polarizing
conditions, most if not all (>98%) the cells remained ZsG
negative (Figure 1D). These results confirm that the ZsG
reporter faithfully reflects T-bet-expressing Th1 cells.
IL-12 and IFN-g Are Redundant in Inducing T-bet
Expression
Both IL-12 and IFN-g have been reported to upregulate T-bet
expression (Oestreich and Weinmann, 2012); however, their
relative contribution in inducing T-bet is unknown. Using CD4+
T cells from TBGR mice, we studied T-bet induction by IL-12
and IFN-g in cells stimulated with anti-CD3 and anti-CD28.
When IL-12 and IFN-g were both neutralized during in vitro
priming, no ZsG induction was detected, whereas virtually all
the TBGR CD4+ T cells were ZsG+ when both IL-12 and IFN-g
were added to the culture (Figure 2A). Addition of either IL-12
or IFN-g alone, while neutralizing the alternative cytokine,
induced ZsG expression in the majority of the cells, although
the mean fluorescence intensity (MFI) was somewhat lower.
To rule out the possibility that IL-12 or IFN-g had been incom-
pletely neutralized, we examined TBGR mice that were singly
(Ifngr1/ or Stat4/) or doubly (Ifngr1/Stat4/) deficient
for IFN-gR1 and Stat4. Naive cells from these mice were primed
with soluble anti-CD3 and anti-CD28 in the presence of IL-12,
IFN-g, and anti-IL-4. Virtually all the wild-type (WT) cells were
ZsG+, but no ZsG+ cells were detected in Ifngr1/Stat4/ cells,
in which both IL-12 and IFN-g signaling are defective (Figure 2B,
upper panel). Nonetheless, most of Ifngr1/ or Stat4/ TBGR
cells expressed ZsG albeit at lower amounts (50% reduction
in MFI) compared to their wild-type counterparts. Greater thanImmunity 37, 660–673, October 19, 2012 ª2012 Elsevier Inc. 661
Figure 1. T-bet-ZsGreen Reporter Faithfully Reflects the Expression of Endogenous T-bet
(A) Splenocytes of naive TBGR mice were stained for CD4, CD8, CD44 and Foxp3. Dot plots were gated on different populations as indicated.
(B) CD4+CD44hi cells from naive TBGRmice were separated into ZsG+ and ZsGneg population by cell sorting. The relative expression amounts of different genes
normalized to Cd4 were assessed by quantitative PCR after reverse transcription.
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T-bet Prevents an Endogenous Th2 Cell Program80%of in vitro-primedwild-type cells expressed IFN-g;50%of
Ifngr1/ and Stat4/ cells were capable of expressing IFN-g
(Figure 2B, lower panel). The MFI of IFN-g was substantially
reduced in the IFN-g+ cells from Stat4/ donors, whereas
IFN-g+ cells from Ifngr1/ mice were almost as bright as those
fromwild-type donors; no IFN-g production by Ifngr1/Stat4/
cells was detected. Therefore, either IL-12 or IFN-g alone can
induce T-bet expression in most cells; similarly, these cells are
still capable of producing IFN-g in vitro.
To study T-bet induction by IL-12 and IFN-g in vivo, we in-
fected TBGR mice with T. gondii, a pathogen that elicits strong
Th1 cell responses (Jankovic et al., 2007), and assessed T-bet
and IFN-g expression 1 week after infection. Similar to the
findings obtained in vitro, deficiency in either IFN-gR1 or Stat4
resulted in a modest reduction in ZsG expression, both in
percentage of positive cells and in MFI of ZsG in these cells (Fig-
ure 2C). By contrast, some CD4+ T cells from Ifngr1/Stat4/
TBGR mice upregulated T-bet, although the proportion that did
so was less than that of singly deficient cells (Figure 2D). These
results indicate that under in vivo conditions, T-bet can be
induced in an IL-12- and IFN-g-independent manner and that
such inducing signal(s) are absent in our in vitro Th1 cell-polar-
izing conditions. Addition of type I IFNs or IL-27 to the culture
of in vitro-differentiating Ifngr1/Stat4/ cells resulted in ZsG
expression (Figure S2), suggesting these cytokines may be
responsible for IL-12- and IFN-g-independent T-bet induction
in vivo.
In contrast to requirements for in vivo T-bet induction, Stat4
deficiency dramatically diminished the capacity of these cells
to produce IFN-g (Figure 2E). Deficiency in IFN-gR1 had a very
small effect on IFN-g production, despite reduced T-bet expres-
sion consistent with a previous report that Stat1 is not required
for the development of IFN-g-producing CD4+ T cells (Lieberman
et al., 2004). Given that Stat4/ TBGR cells expressed similar
amounts of ZsG as Ifngr1/ TBGR cells did (Figure 2C), the
differential IFN-g production by these cells implies that Stat4
has an effect on IFN-g production in addition to its role in
inducing T-bet and that T-bet without STAT4 does not induce
optimal IFN-g production.
T-bet and Stat4 Synergize in Inducing IFN-g Production
T-bet is regarded as a critical regulator of Th1 cells and directly
regulates IFN-g production by binding to several conserved
sites at the Ifng locus (Hatton et al., 2006). However, Stat4
also appears to directly regulate IFN-g production as shown
by the dramatic reduction of IFN-g production with only a
modest decrease of ZsG expression in Stat4/ TBGR mice.
To investigate the relative importance of T-bet and Stat4 in
regulating T-bet and IFN-g production, we generated T-bet
singly deficient (Tbx21/) and Stat4-T-bet doubly deficient
(Stat4/Tbx21/) TBGR mice. Our unique model of the
T-bet-ZsGreen reporter crossed to Tbx21/ background also(C) Splenocytes from naive TBGR mice were stained for CD4, Foxp3, and T-bet.
(low, intermediate, and high) as indicated. Shaded histograms represent T-bet s
(D) Sorted naive CD62LhiCD44loCD25negZsGnegCD4+ T cells from TBGR mice we
expression of T-bet-ZsGreen was assessed by flow cytometric analysis.
Numbers indicate the percentage of cells in each quadrant or gate. Error bars
experiments.allows us to address the role of endogenous T-bet in controlling
its own expression.
Tbx21/ TBGR cells primed in vitro in the presence of IL-12
and IFN-g expressed amounts of ZsG similar to comparably
treated WT cells, indicating that T-bet is not required for its
own expression in the presence of IL-12 and IFN-g (Figure 3A).
A deficiency in Stat4 resulted in a modest reduction of ZsG
expression similar to the results shown in Figure 2. T-bet
deficiency in the setting of Stat4 deficiency did not result in
a further reduction of ZsG expression when the cells were
stimulated in the presence of exogenous IL-12 and IFN-g,
indicating that T-bet does not participate in IFN-g-mediated
T-bet upregulation in vitro. Of course, T-bet could still affect
its own expression indirectly through its regulation of IFN-g
production. Indeed, at a steady state, Tbx21/ TBGR cells
express lower amounts of ZsG compared to WT TBGR cells
(data not shown).
In response to T. gondii infection, Tbx21/ TBGR cells ex-
pressed close to normal amounts of ZsG, implying that T-bet
is dispensable for its own expression in vivo as well as in vitro
(Figure 3B). However, a combination of Stat4 and T-bet defi-
ciency resulted in dramatic reduction in the amounts of ZsG
expression in CD4+ T cells from T. gondii-infected mice in the
ZsG+ cells. Such a reduction was not observed in in vitro-
cultured Stat4/Tbx21/ TBGR cells that had received ex-
ogenous IFN-g. Double deficiency in Stat4 and IFN-gRI in
T. gondii-infected mice only resulted in reduction in the
frequency of ZsG+ cells but not the mean fluorescence intensity
(MFI) of ZsG in ZsG+ cells compared to Stat4 single deficiency
(Figure 2C). These results imply that T-bet may participate
in its own expression in instances in which the third, yet
unknown, signaling pathway is responsible for T-bet expression.
Nonetheless, T-bet or Stat4 deficiency alone caused substantial
reduction in the frequency of IFN-g-producing cells and the
combination of T-bet and Stat4 deficiency completely abolished
IFN-g production (Figure 3C).
T-bet Suppresses IL-4 and GATA3 Expression
during T. gondii Infection
T-bet has been reported to suppress Th2 cell differentiation
when it is overexpressed (Szabo et al., 2000; Usui et al.,
2006). When Tbx21/ mice are infected with Leishmania
major, IFN-g production is dramatically reduced while IL-4
production is induced (Szabo et al., 2002). Given that
L. major elicits Th1 cell responses in C57BL/6 mice and Th2
cell responses in BALB/c mice, it is likely that, in the absence
of T-bet, the environment for CD4+ T cell differentiation may
have been switched from favoring Th1 to favoring Th2 cell
differentiation. On the other hand, T. gondii infection elicits
strong Th1 cell responses both in C57BL/6 and BALB/c mice.
The WT and Tbx21/ TBGR mice allow us to examine the
role of T-bet in inducing Th1 and suppressing Th2 cellHistograms were gated on different populations on the basis of ZsG intensity
taining in CD4+Foxp3negZsGneg cells.
re activated under Th1, Th2, or Th17 cell-polarizing conditions for 3 days. The
represent means ± SD. Data are representative of at least two independent
Immunity 37, 660–673, October 19, 2012 ª2012 Elsevier Inc. 663
Figure 2. IL-12 and IFN-g Are Redundant in Inducing T-bet Expression
(A) Naive CD4+ T cells were cultured under modified Th1 cell-polarizing conditions as indicated (with anti-IL-4 included) for 3 days.
(B) Naive CD4+ T cells from various strains were cultured under Th1 cell-polarizing conditions (IL-12 and anti-IL-4) in the presence of exogenous IFN-g for 3 days.
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T-bet Prevents an Endogenous Th2 Cell Programresponses in the strongly Th1 cell-inducing environment of
T. gondii infection; TBGR expression can be used as a readout
of CD4+ T cells differentiating toward Th1 cell direction both in
WT and Tbx21/ TBGR mice.
ZsG+ cells from WT TBGR mice expressed IFN-g but no IL-4
after T. gondii infection; however, IL-4 production was detected
in 20% of ZsG+ cells from infected Tbx21/ TBGR mice (Fig-
ure 4A). Interestingly, some of these IL-4-producing cells also
produced low amounts of IFN-g. On the other hand, ZsGneg
cells from infected T-bet deficient TBGR mice did not produce
IL-4. These results suggest that IL-4-producing T-bet-deficient
cells developed in the presence of signals typically resulting in
Th1 cell differentiation. Although Ifng mRNA was strikingly
reduced in the ZsG+ cells from T-bet deficient TBGR mice, Il4
mRNA was dramatically induced in these Tbx21/ZsG+
‘‘Th1’’ cells (Figure 4B). Gata3 mRNA was also induced in the
absence of T-bet, suggesting the signals involved in upregulat-
ing T-bet expression are not sufficient to directly suppress
GATA3 in the absence of T-bet. Intracellular staining for
GATA3 confirmed that GATA3 expression was much higher in
Tbx21/ZsG+ ‘‘Th1’’ cells than in wild-type Th1 cells (Fig-
ure 4C). These data show that in the absence of T-bet,
Tbx21/ mice are still capable of generating T-bet-inducing
signals after T. gondii infection, presumably from innate cells.
Indeed, serum concentration of IL-12 was comparable between
WT and Tbx21/ mice that were infected with T. gondii (data
not shown).
Suppression of Th2 Cell-Specific Gene Expression
by T-bet Is CD4+ T Cell Intrinsic
To determine whether the effect of T-bet in suppressing IL-4 is
CD4+ T cell intrinsic, we transferred naive CD4+ T cells from
WT or Tbx21/ TBGR mice into WT recipients prior to infecting
the recipients with T. gondii. Unfortunately, the number of trans-
ferred cells recovered in this type of experiment was quite low,
probably because of massive Th1 cell response of the endoge-
nous CD4+ T cells. Therefore, we transferred naive CD4+
T cells from WT and Tbx21/ TBGR mice into Tcra/ mice, in
which homeostatic proliferation of the transferred cells is ex-
pected. Interestingly, 3 weeks after transfer, approximately half
of the transferred cells had become ZsG+ (data not shown).
Restimulation of transferred cells resulted in IFN-g production
mainly by the ZsG+ cells and modest amounts of IL-4 from the
ZsGneg cells from the WT donors (Figure 5A). In contrast, among
cells from the Tbx21/ donors, 15%–20% of both the ZsG+ and
ZsGneg cells produced IL-4 but only 2%–3% produced IFN-g.
This result indicates that T-bet plays a critical cell-intrinsic posi-
tive role in Th1 cell differentiation and negative role in Th2 cell
differentiation in homeostatic proliferation just as it does in
T. gondii infection.
IL-4 plays a major role in Th2 cell differentiation in vitro.
However, many in vivo Th2 cell-associated responses are either
independent of the IL-4-Stat6 pathway or only partially depen-
dent upon it. T-bet deficiency leads to upregulation of Th2 cell(C–E) Various mouse strains were infected with T. gondii for 7 days. Cells ha
was assessed by flow cytomteric analysis. IFN-g production was assessed by int
anti-CD3 plus anti-CD28 (E) for 4 hr. Histogram plots were gated on CD4+CD44hi c
gate. Error bars represent means ± SD. Data are representative of three (A and Bsignature genes even in the cells expressing the T-bet reporter,
suggesting that in the absence of T-bet, Th2 cell differentiation
proceeds without ‘‘conventional’’ exogenous Th2 cell inducing
stimuli. Indeed, culturing naive Tbx21/ TBGR CD4+ T cells
in vitro under ‘‘Th1’’ cell differentiation conditions (i.e., anti-
CD3, anti-CD28, IL-12, and anti-IL-4), although it led to virtually
all the responding cells being ZsG+, resulted in a substantial
percentage of these cells being able to produce IL-4 in response
to phorbol myristate acetate (PMA) and ionomycin (Figure 5B).
Thus, under classical Th1 cell-polarizing conditions, in which
IL-4 is neutralized, the absence of T-bet allows Th2 cell differen-
tiation to go forward in at least a portion of the cells under study.
T-bet and GATA3 Cross-regulation Affects Many Th1
and Th2 Cell-Specific Genes
To further explore the mechanisms of T-bet-mediated gene
regulation, we performed a T-bet ChIPseq to map T-bet binding
sites genome-wide in WT Th1 cells. Modification-specific
histone ChIPseq as well as RNaseq were carried out with WT
and Tbx21/ TBGR+ Th1 cells so that genes regulated by
T-bet could be identified.
RNaseq results showed that 219 and 211 genes were
positively or negatively regulated by T-bet, respectively,
with >2-fold change between WT and Tbx21/ cells (Figure 6A,
upper panels). ChIPseq results indicated that T-bet bound to
2493 genes in Th1 cells; in the absence of T-bet, H3K4me1
and H3H27me3modification peaks within 4173 and 2875 genes,
respectively, were reduced (at least one peak per gene). Overall,
only 4% and 2% of the T-bet bound genes were positively
and negatively regulated by T-bet at a transcriptional level,
respectively (Figure 6A, lower left). Among the 1183 genes that
were bound by T-bet and displayed reduced H3K4me1 modifi-
cation in the absence of T-bet, the percentage of the genes
that were positively regulated by T-bet was increased to 7%,
whereas, the percentage of the genes that were negatively regu-
lated by T-bet remained 2%. On the other hand, among the
663 genes that were bound by T-bet and displayed reduced
H3K27me3 modification in the absence of T-bet, the percentage
of the genes that were negatively regulated by T-bet was en-
riched to 4%, whereas the percentage of the genes that are
positively regulated by T-bet remained the same as that of the
total T-bet-bound genes. In the absence of T-bet, 47% and
27% of the total 2493 T-bet-bound genes displayed reduced
H3K4me1 and H3K27me3, respectively (Figure 6A, lower right).
Higher percentages of T-bet-bound genes were regulated by
T-bet in histonesmodifications than in gene expression suggest-
ing T-bet may regulate gene expression at an epigenetic level.
Among the 97 genes that were bound and positively regulated
by T-bet, 82% had reduced H3K4me1 modification in the
absence of T-bet, whereas among the 45 genes that were bound
and negatively regulated by T-bet, 58% displayed reduced
H3K27me3 in the absence of T-bet. Therefore, T-bet may
promote H3K4me1 or H3K27me3 modifications through which
it positively or negatively regulates gene expression.rvested from spleens were characterized. The expression of T-bet-ZsGreen
racellular staining after stimulation with PMA plus ionomycin (B) or plate-bound
ells. Numbers indicate the percentage and the MFI of the positive cells in each
) and two (C–E) independent experiments.
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Figure 3. T-bet and Stat4 Synergize in Inducing IFN-g Production but T-bet Does Not Regulate Its Own Expression in the Presence of IL-12
and IFN-g
(A) Naive CD4+ T cells from various strains were cultured under Th1 cell-polarizing conditions (IL-12 and anti-IL-4) in the presence of exogenous IFN-g for 3 days.
(B and C) Various mouse strains were infected with T. gondii for 7 days. Cells harvested from spleens were characterized. The expression of T-bet-ZsGreen was
assessed by flow cytometric analysis. IFN-g productionwas assessed by intracellular staining after stimulationwith plate-bound anti-CD3 plus anti-CD28 for 4 hr.
Histogram plots were gated on CD4+CD44hi cells. Error bars represent means ± SD. Data are representative of two independent experiments.
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T-bet Prevents an Endogenous Th2 Cell ProgramT-bet bound to the Ifng, Il12rb2, and Cxcr3 loci and promoted
H3K4me1 modification around the binding sites of the genes
(Figures 6B–6D). At the Ifng locus, T-bet bound to many sites666 Immunity 37, 660–673, October 19, 2012 ª2012 Elsevier Inc.including CNS-6 (6 kb upstream of transcription start site) at
which H3K4me1 modification was dramatically reduced in the
absence of T-bet (Figure 6B). Similarly, T-bet bound to an intron
Figure 4. T-bet Suppresses IL-4 and GATA3
Expression during T. gondii Infection
Wild-type (WT) or T-bet deficient (Tbx21/) TBGR mice
were infected with T. gondii for 7 days. Cells harvested
from spleens were characterized.
(A) IFN-g and IL-4 production was assessed by intracel-
lular staining after stimulation with plate-bound anti-CD3
plus anti-CD28 for 4 hr. Histogram plots were gated on
CD4+ZsGneg and CD4+ZsG+ cells. Numbers indicate the
percentage of cells in each quadrant.
(B) CD4+ZsG+ cells from were sorted. The relative ex-
pression amounts of different genes were assessed by
quantitative PCR after reverse transcription. Error bars
represent means ± SD.
(C) T-bet and GATA3 expression were assessed by
intracellular staining. Histogram plots were gated on
CD4+Foxp3negZsG+ cells.
Data are representative of two independent experi-
ments.
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T-bet Prevents an Endogenous Th2 Cell Programof the Il12rb2 and the 50 enhancer of the Cxcr3; without T-bet,
H3K4me1 modification was reduced around these binding sites
(Figures 6C and 6D). On the other hand, T-bet directly sup-Immunity 37, 660pressed the expression of CCR6, a Th17 cell-
specific chemokine receptor; T-bet bound to
an intron of the Ccr6 gene and promoted
H3K27me3 around this binding site. Previously,
T-bet has been reported to suppress Runx1-
mediated RORgt upregulation (Lazarevic
et al., 2011). Although we did not detect
increased expression of RORgt in T-bet-
deficient ‘‘Th1’’ cells, our data indicate T-bet
also binds to the Rorc gene and promotes
H3K27me3 around its binding site (Figure S3).
Because we noticed that T-bet deficient
‘‘Th1’’ cells produce IL-4, which is a signature
Th2 cell cytokine, we analyzed gene regulation
of Th1 and Th2 cell-specific genes by T-bet
at a genome-wide level. We have previously
identified 90 Th1 and Th2 cell-specific genes
(Wei et al., 2011). Approximately 50% of the
Th1 cell-specific genes were positively regu-
lated by T-bet (Figure 7A). Interestingly, 26
out of 90 Th2-specific genes were negatively
regulated by T-bet. Genes positively regulated
by T-bet included many well-known Th1 cell-
specific genes such as Cxcr3, Ifng, Nkg7,
Fasl, Il12rb2, Txk, Il18r1, and Lta (Figure 7B,
left side). Genes that were negatively regulated
by T-bet included dozens of Th2 cell-specific
genes such as Ecm1, Pparg, Ccr4, Fos, Il5,
Il4, Ccr1, and Il13 (Figure 7B, right side).
Interestingly, T-bet bound to all these Th1
cell-specific genes but only one of the
negatively regulated Th2 cell-specific genes.
Indeed, we have reported that all these Th2
cell-specific genes as well as some of these
Th1 cell-specific genes are bound by GATA3
in Th2 cells (Wei et al., 2011). At the genomelevel, T-bet bound to and positively regulated 60% of the
44 Th1 cell-specific genes. Although T-bet bound to and
negatively regulated only 20% of the 26 Th2 cell-specific–673, October 19, 2012 ª2012 Elsevier Inc. 667
Figure 5. Suppression of Th2 Cell-Specific Gene Expression by
T-bet Is CD4+ T Cell Intrinsic
(A) Naive CD4+ T cells from WT and Tbx21/ TBGR mice were sorted and
transferred into Tcra/ mice. Three weeks later, splenocytes were harvested
and cytokine production was assessed by intracellular staining after PMA plus
ionomycin stimulation. The percentage of cytokine-producing cells was
calculated within CD4+ZsGneg and CD4+ZsG+ subsets. Error bars represent
means ± SD.
(B) Naive CD4+ T cells were cultured under Th1 cell-polarizing conditions (IL-12
and anti-IL-4) for 3 days. IFN-g and IL-4 production was assessed by intra-
cellular staining after stimulation with PMA plus ionomycin. Numbers indicate
the percentage of cells in each quadrant.
Data are representative of two (A) and three (B) independent experiments.
Immunity
T-bet Prevents an Endogenous Th2 Cell Programgenes, GATA3 bound to 70% of these genes. Thus, it is likely
that the upregulation of these Th2 cell-specific genes in the
Tbx21/ ‘‘Th1’’ cells is due to the enhanced GATA3 function
as well as expression that occurs in the absence of T-bet.
Indeed, T-bet strongly bound to at least two sites around the
Gata3 locus (Figure 7D, upper panel). In keeping with a modest668 Immunity 37, 660–673, October 19, 2012 ª2012 Elsevier Inc.upregulation of GATA3 expression in T-bet-deficient Th1 cells
(1.7-fold increase), histone H3 tri-methylation at position K27
(H3K27me3), a suppressive histone mark, found in the imme-
diate vicinity of these two T-bet binding sites at the Gata3 locus,
was substantially reduced in T-bet-deficient Th1 cells when
compared to that of WT Th1 cells (Figure 7D, lower panel).
Therefore, T-bet may directly inhibit GATA3 expression in Th1
cells possibly by promoting H3K27me3 modification at the
Gata3 locus in addition to the ability of T-bet in inhibiting
GATA3 function through protein-protein interaction as previously
reported (Hwang et al., 2005).
Thus, the balance between T-bet and GATA3 during T cell
differentiation plays a critical role in determining the expression
of Th1 and Th2 lineage-specific genes and without T-bet
induction, GATA3 drives Th2 cell differentiation in the absence
of IL-4.
DISCUSSION
We prepared the TBGR indicator mouse strain allowing us to
study Th1 cell differentiation both in vitro and in vivo. We showed
that ZsG expression faithfully reflects endogenous T-bet ex-
pression. Using this T-bet reporter system, we could study the
regulation of T-bet at a single-cell level with a greater sensitivity
both in vitro and in vivo thanwas previously possible. Either IL-12
or IFN-g alone was sufficient to induce T-bet expression in
cells responding to TCR and CD28 signals. Cells from Ifngr1/
Stat4/ TBGR mice cultured under Th1 cell-polarizing condi-
tions showed no induction of ZsG indicating that, under these
in vitro conditions, T-bet induction requires at least IL-12 or
IFN-g. Interestingly, the majority of the Ifngr1/Stat4/ TBGR
cells were still able to upregulate ZsG expression in response
to T. gondii infection, indicating that stimuli other than IFN-g
and IL-12 are capable of inducing T-bet in vivo in activated cells
and such stimuli are not present during in vitro culture. We have
observed high dose antigen stimulation can induce T-bet in vitro;
however, such T-bet induction is largely dependent on endoge-
nous IFN-g. Thus, it is unlikely that the in vivo T-bet expression
by Ifngr1/Stat4/ TBGR cells is due to a strong TCR stimu-
lation. Type I IFNs or IL-27, when exogenously added, was
able to induce ZsG in Ifngr1/Stat4/ TBGR cells in vitro;
thus, it is possible that these cytokines are responsible for IL-
12- and IFN-g-independent induction of T-bet in vivo. Further
investigation is required to confirm such regulation.
We also found that T-bet was not required for its own induction
when IL-12 or IFN-g are present given that ZsG is expressed
at the same amounts in both WT and Tbx21/ TBGR cells in
response to T. gondii infection or when cultured in vitro under
Th1 cell-polarizing conditions. Nonetheless, T-bet may be
involved in directly promoting its own expression when induced
by the ‘‘IL-12- and IFN-g-independent’’ pathway, given that the
ZsG expression is much lower in Stat4/Tbx21/ TBGR cells,
which express no IFN-g, than in Ifngr1/Stat4/ TBGR cells.
Consistent with a redundant role of IFN-g and IL-12 in inducing
T-bet, cells that fail to respond to IFN-g, specifically Ifngr1/
cells, were still able to produce IFN-g at a level comparable to
that found in WT cells, especially in vivo. These results suggest
the positive feedback loop mediated by IFN-g makes only
a limited contribution to full Th1 cell differentiation under the
Figure 6. T-bet Directly Regulates Many Key Molecules of Th1 and Th17 Cells
Naive CD4+ T cells fromWT and Tbx21/ TBGRmice were cultured under Th1 cell-polarizing conditions for 3–4 days. After resting in IL-2-containingmedium for
2 days, cells were sorted for ZsG+ and further expanded under Th1 cell-polarizing conditions for another 3–4 days. Anti-T-bet and histone ChIPseq as well as
RNaseq were carried out.
(A) The Venn diagrams show the overlap of genes that are bound by T-bet, positively (upper left) or negatively (upper right) regulated by T-bet at a transcriptional
or epigenetic level in Th1 cells. The association of histone modifications and gene regulation were determined in subgroups of the genes that are bound by
T-bet (lower panels). DEG-P and DEG-N stand for differentially expressed genes (DEG) that are regulated by T-bet positively (P) or negatively (N).
(B–E) UCSC genome browser view of T-bet binding, H3K4me1 or H3K27me3 modifications at the Ifng (B), Il12rb2 (C), Cxcr3 (D), and Ccr6 (E) locus are shown.
Dotted boxes indicate differences in epigenetic modifications between WT and Tbx21/ cells around the T-bet binding sites. Arrows indicate the direction of
the genes.
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Figure 7. T-bet Directly Induces Th1 Cell-
Related Genes but Indirectly Suppresses
Th2 Cell-Related Genes through Acting on
GATA3
(A) The Venn diagram shows overlap of genes that
are Th1 or Th2 cell specific, positively or negatively
regulated by T-bet in Th1 cells.
(B) FPKM values were extracted from RNaseq
data in duplicates. Selected Th1- and Th2 cell-
specific genes were shown. Asterisks and carets
mark the genes that are bound by T-bet in Th1
cells and byGATA3 in Th2 cells, respectively. Error
bars represent means ± SD.
(C) The plots show the percentages of the genes
that are bound by T-bet and/or GATA3 in each
category.
(D) UCSC genome browser view of T-bet binding
and H3K27me3 modification at the Gata3 locus
is shown. Numbers indicate the sums of RPBM
(reads per base per million reads in library) values
in the box. The arrow indicates the direction of
the Gata3 gene.
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feedback will become critical for Th1 cell responses when limited
or no IL-12 is present. On the other hand, although T-bet
amounts in Stat4/ cells were similar to those in Ifngr1/ cells,
Stat4/ cells expressed much lower IFN-g than Ifngr1/ cells,
suggesting that Stat4 is critical for collaborating with T-bet in
inducing IFN-g production as previously reported in an in vitro
culture system (Thieu et al., 2008). Indeed, Stat4 directly binds
to the Ifng locus (Wei et al., 2010). The importance of Stat4 is
particularly evident when no exogenous IFN-g was provided;
Stat4/ cells produced less IFN-g and, therefore, such cells
not only had an IL-12 signaling defect but also received less
IFN-g stimulation. Either Stat4 or T-bet was able to induce
some IFN-g production but together they could collaborate to
induce maximal IFN-g production; no IFN-g production could
be detected in Stat4/Tbx21/ cells either in vitro or in vivo.
Thus, these two factors both play critical roles in inducing
IFN-g during Th1 cell responses and Stat4 is responsible for
T-bet-independent IFN-g production.
It is common that during a particular type of Th cell differenti-
ation, the specific program involved also actively inhibits the
capability of the differentiating cells to become cells of other
Th cell phenotypes (Zhu and Paul, 2010). Transcription factors
induced in each lineage, particularly the critical regulators, are
often involved in such cross-regulation. For example, GATA3
not only represses Stat4 expression (Usui et al., 2003), but also
suppresses Runx3-mediated IFN-g induction (Yagi et al., 2010)
and modifies the Tbx21 locus during Th2 cell differentiation
(Wei et al., 2011). On the other hand, when overexpressed,
T-bet suppresses GATA3 expression at the transcriptional level
(Usui et al., 2006). T-bet also suppresses GATA3 function
through protein-protein interaction (Hwang et al., 2005). T-bet
and GATA3 share many target genes when coexpressed (Jenner
et al., 2009). Here, we have shown that endogenous T-bet is
critical for inhibiting GATA3 function during both in vitro and
in vivo Th1 cell differentiation, preventing these ‘‘Th1-differenti-670 Immunity 37, 660–673, October 19, 2012 ª2012 Elsevier Inc.ating’’ cells from activating a ‘‘default’’ Th2 cell differentiation
program, a program that they do activate when T-bet is absent.
Although cultured Th2 cells express the highest amounts of
GATA3 among Th cells, all CD4+ T cells, including naive cells,
express GATA3 (Wei et al., 2011). The expression of GATA3 is
upregulated during Th2 cell differentiation and downregulated
during Th1 and Th17 cell differentiation in vitro. However, under
certain circumstances, Th2 cell differentiation may occur with
low amounts of GATA3 expression, although such GATA3
continues to be essential (Zhu et al., 2003). Stat5 activation is
a second critical element for IL-4 production and thus Th2 cell
differentiation (Cote-Sierra et al., 2004; Zhu et al., 2003). Stat5
is the key signaling molecule for most members of the gc family
cytokines, including IL-2 and IL-7 (Rochman et al., 2009).
Unlike GATA3, the other two key transcription factors, T-bet
and RORgt, are not expressed by naive CD4+ T cells. Similarly,
Stat4 and Stat3 activation are usually triggered by cytokines,
such as IL-12 and IL-6, produced by APCs, whereas Stat5 can
be activated by IL-2 that is produced by CD4+ T cells upon
activation. Therefore, basal expression of GATA3 as well as
continuous autocrine activation of Stat5 in naive and freshly
activated CD4+ T cells provide an internal Th2 cell differentiating
setting and thus lead to Th2 cell differentiation without an
exogenous source of cytokines. Thus, it could be argued that
unless specifically prevented, Th2 cell differentiation is likely to
occur without a requirement for specific inducing cytokines
produced by APCs or other accessory cells.
Over the years, immunologists have struggled to determine
how Th2 cell-associated responses are initiated physiologically
(Paul and Zhu, 2010). APCs can produce IL-12 that drives Th1
cell differentiation or TGFb or IL-6 that induce Th17 cell differen-
tiation. However, IL-4 is not produced by conventional APCs.
Recent reports have raised the possibility that basophils may
serve as APCs and coupled with their capacity to produce IL-4
and possibly TSLP may act as determinants of Th2 cell differen-
tiation (Perrigoue et al., 2009; Sokol et al., 2008; Sokol et al.,
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essential for Th2 cell-associated responses in vivo so that these
capabilities of basophils, even if they are confirmed as potent
APCs, may not prove to be essential for the Th2 cell bias they
have been reported to exert. Indeed, basophils are not required
for Th2 cell differentiation in response to Nippostrongylus
brasiliensis infection (Kim et al., 2010). Low-dose antigen
stimulation or weak antigen presentation have been proposed
as another model of Th2 cell differentiation (Steinfelder et al.,
2009; Yamane et al., 2005); the Schistosoma mansoni egg
product omega-1 has been reported to diminish dendritic cell
function, presumably creating a low TCR signal strength environ-
ment. Nonetheless, there is as yet no convincing data showing
that either mechanism is essential for Th2 cell induction. Our
report here clearly shows that even under a strong Th1 cell-
biasing stimulation either in vitro or in vivo, evident by the
induction of T-bet reporter, in the absence of T-bet, such cells
become Th2-like cells. The failure of CD4+ T cells in IL-12-
deficient mice to default to a Th2 cell program in a Th1 cell-
inducing environment may be explained by induction of T-bet
induction by signals other than IL-12.
In conclusion, by using a T-bet reporter mouse strain cross-
bred to various gene-deficient mouse strains, we have carefully
dissected the network of multiple cytokine pathways elicited by
IL-12 and IFN-g, and the role of Stat4 and T-bet in the induction
of Th1 and Th2 cell signature molecules during in vivo Th1
responses. Our results also strongly indicate that Th2 cell
differentiation may occur without CD4+ T cells receiving dif-
ferentiation-biasing signals from APCs, consistent with this
being a ‘‘default’’ pathway.
EXPERIMENTAL PROCEDURES
Mice and Cell Culture
Tbx21/ mice (line 4648) and Ifngr1/ (line 3288) were obtained from
Jackson laboratory (Szabo et al., 2002). Stat4/ mice have been previously
described (Kaplan et al., 1996) and they have been backcrossed to C57BL/6
background. C57BL/6 Tcra/ (line 98) mice were obtained from Taconic.
The C57BL/6 T-bet-ZsGreen reporter (TBGR) mouse strain was generated
as described in Supplemental Experimental Procedures. In brief, the coding
region of ZsGreen was inserted into the ATG translational starting site of
a genomic fragment encoding T-bet in the BAC clone (RP23-237M14) by
recombineering technology with the galK replacement method so that T-bet
expression from the BAC was replaced by GFP expression. The modified
BAC clone, after sequence verification of manipulated region, was used
for generating transgenic mice by pronuclear microinjection of fertilized
C57BL/6 eggs. The offspring of the founder (B6-Tbet-ZsGreen-E3) that carried
only one copy of the transgene were selectivelymaintained and bred to various
mouse strains deficient in different genes. The TBGR mice were genotyped
with the following primers: ZsGreen (F), 50-AAG GGC GAC GTG AGC ATG
T-30 and ZsGreen (R), 50-CAC GGA CTT GGC CTT GTA CAC-30. All the mice
were bred and maintained in the NIAID-specific pathogen free animal facility
and the experiments were done when mice were at 8–16 weeks of age under
protocols approved by the NIAID Animal Care and Use Committee.
Cell Preparation and Activation
Naive CD62LhiCD44loCD25negZsGnegCD4+ T cells were sorted by FACSAria
(BD Biosciences). For adoptive transfer experiments, naive CD4 T cells were
sorted for ZsGnegCD45RbhiCD25neg[CD8/B220/IAb/CD11b/CD11c/CD24/
CD16/CD32/NK1.1]neg fraction. T cell-depleted splenocytes were prepared
by incubation with anti-Thy1.2 mAb supernatant and rabbit complement
(Cedarlane Laboratories Limited) at 37C for 45 min followed by irradia-
tion at 30 Gy (3,000 rad). Naive CD4+ T cells were cultured with irradiatedT cell-depleted splenocytes at a ratio of 1:5 in the presence of 1 mg/ml of
anti-CD3 (145-2C11) and 3 mg/ml of anti-CD28 (37.51) for 3–4 dayswith various
combinations of antibodies and cytokines: For Th1 cell conditions, 10 IU/ml of
hIL-2, 10 ng/ml of IL-12, and 10 mg/ml anti-IL-4 (11B11) (some Th1 cell cultures
include 10 ng/ml IFN-g as specified); for Th2 cell conditions, 50 IU/ml of hIL-2,
5000 U/ml of IL-4, 10 mg/ml anti-IL-12 (C17.8), and anti-IFN-g (XMG1.2); for
Th17 cell conditions, 1 ng/ml TGFb, 10 ng/ml IL-6, 10 ng/ml IL-1b, 10 mg/ml
anti-IL-4, 10 mg/ml anti-IL-12, and anti-IFN-g. The activated cells were then
cultured in RPMI-1640 medium with 10% FBS that contains IL-2 (50 U/ml for
Th1 and 100 U/ml for Th2) or cytokine-free medium for Th17 cells.
Toxoplasma gondii Infection
T. gondii cysts (the avirulent strain ME-49) were prepared from the brains of
infected C57BL/6 mice. Mice were inoculated i.p. with an average of 20 cysts
per animal and splenocytes were analyzed 1 week after infection.
Flow Cytometric Analysis
Cell surface molecules such as CD4, CD8, CD44, CD25, and CD62L were
stained in PBS with 0.5% BSA. Cytokine intracellular staining was performed
as previously described (Zhu et al., 2004). In brief, the activated cells were
restimulated with10 ng/ml phorbol 12-myristate 13-acetate (PMA) and
500 nM ionomycin in the presence of 2 mM monensin for 4 hr. Splenocytes
harvested from T. gondii-infected mice were harvested and stimulated with
plate-bound anti-CD3/anti-CD28 (3 ug/ml of each used for coating) for 4 hr
in the presence of monension. At the end of stimulation, cells were washed
and fixed with 4% paraformaldehyde for 10 min at room temperature and
permeabilized in PBS containing 0.5% Triton X-100 and 0.1% BSA. They
were then stained for cytokines together with CD4 and CD44. Data were
collected with LSR II (BD Biosciences) and results were analyzed with FlowJo
software (Tree Star). All the antibodies for staining cell surface markers or
cytokines were purchased from either BD Biosciences or eBiosciences.
Staining of the transcription factors were carried out with Foxp3 Staining
Buffer Set (eBioscience) in accordance with the manufacturer’s instructions.
Anti-GATA3 (L50-823), anti-Foxp3 (FJK-16s) and anti-T-bet (4B10) were
purchased from BD Biosciences and e-Biosciences, respectively.
RNA Purification and Quantitative PCR
Total RNAs were isolated with a combination of TRIzol (Invitrogen) and
RNeasy Kit (QIAGEN). cDNAs were prepared with SuperScript III Reverse
Transcriptase (Invitrogen). Quantitative PCR was performed on a 7900HT
Sequence Detection System (Applied Biosystems) with the following
predesigned primer and probe sets: Il4, Ifng, Tbx21, Cd4 (all purchased from
Applied Biosystems), and Gata3 as previously described (Zhu et al., 2004).
ChIP-Seq and RNA-Seq
ChIP-Seq experiments were performed as previously described (Barski et al.,
2007). In brief, chromatin was prepared by sonication from the cells cross-
linked with 1% formaldehyde for 10 min and immunoprecipitated with the
anti-T-bet antibody (sc-21749, Santa Cruz). For histone ChIPseq, cells were
treated with MNase to generate80%mononucleosomes and 20% dinucleo-
somes. Antibodies against histone H3K4me1 (ab8895, Abcam) and
H3K27me3 (07-449, Upstate) were used. The ChIP DNA was blunt-ended,
ligated to the Solexa adaptors, amplified, and sequenced with an Illumina
HiSeq system. Detailed data analyses are described in Supplemental Experi-
mental Procedures.
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All the ChIPseq and RNaseq data are available in the Gene Expression
Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/gds) under the acces-
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